SUMMARY Specimens of human rheumatoid and nonrheumatoid synovial lining were maintained in nonproliferative organ culture for 20 hours. The culture fluids were then assayed for prostaglandin Es (PGE2), thromboxane B, (TXB2), and 6-keto-prostaglandin F1-(6-keto-PGFsa) by specific radioimmunoassay. The presence of each of these substances was confirmed by gas chromatography and mass spectrometry. Rheumatoid tissue produced significantly more of each cyclo-oxygenase product than nonrheumatoid tissue.
The initial step in the biosynthesis of prostaglandins from the unsaturated fatty acid precursor (for example, arachidonic acid) is the formation of unstable cyclic endoperoxides (PGG2 and PGH2) by the enzyme fatty acid cyclo-oxygenase. The endoperoxides can be converted to thromboxane A2 (TXA,), prostacyclin (PGI2), or the 'primary' prostaglandins (PGE2, PGD2, and PGF2a) (review1).
It is now generally accepted that 'primary' prostaglandins, in particular PGE2, are important inflammatory mediators (review2). These Biopsy specimens of human synovial lining were taken either at arthrotomy for internal derangement or at synovectomy. The nonrheumatoid specimens were taken from the knee, either from quiescent joints or from otherwise normal joints after recent mechanical trauma. The rheumatoid specimens were taken mainly from the knee during synovectomy from patients who had 'definite' or 'classical' disease according to the diagnostic criteria of the American Rheumatism Association. '3 All specimens were removed in a bloodless field within 10 min of the application of the tourniquet and were transferred to the laboratory in a sterile container on a gauze moistened with Trowell's T-8 culture medium (Gibco). The tissue was cut into segments, each of approximately 4 x 4 mm planar surface and of the thickness of the membrane (not exceeding 4 mm). These were maintained individually in Trowell's nonproliferative adult organ maintenance culture at the relevant pH for the tissue.'4 For some segments the culture medium con- The medium was then withdrawn, snap-frozen to -70°C and stored at -20°C. 
Results
The results presented in Tables 1 and 2 and Fig. 1 product (Table 2 ). In 2 out of 6 cultures of nonrheumatoid tissues TXB2 was not detected ( Table 1) . The mean production of each cyclo-oxygenase product by rheumatoid tissue was significantly higher than mean values for the nonrheumatoid group (Fig.  1 ). Indomethacin (10-' to 10-' M) caused a dosedependent inhibition of the generation of each cyclo-oxygenase product and in tissues from 7 different patients 10 ' M indomethacin suppressed cyclo-oxygenase activity by at least 85%.
Discussion
The results presented in this paper confirm the observations that synovial lining explants produce PGE256 and support the findings that rheumatoid synovium has a greater prostaglandin synthetase capacity than nonrheumatoid synovium.8 19 They also show that these tissues are capable of generating thromboxanes and prostacyclin, though PGE2 is the predominant product in both groups. It is possible therefore that the TXB2 and 6-keto-PGF,a detected in synovial fluids8" originate from synovial tissue.
Prostacyclin, like PGE2, is a potent vasodilator and hyperalgesic agent,2 and generation of prostacyclin as well as PGE, by inflamed tissues could contribute to inflammatory symptoms such as erythema, oedema, and pain. The role of thromboxanes in inflammation is less clear. Thromboxane A, is a potent vasoconstrictor and aggregator of platelets,' and these properties may reduce haemorrhage at an inflamed site. Also, thromboxane B2 has been reported to have chemotactic activity for leucocytes.2" There are, however, no reports as yet which indicate that thromboxanes are important inflammatory mediators. The increased cyclo-oxygenase activity in rheumatoid tissue may be fundamental to the rheumatoid process, or it may be a less specific consequence of the pathology of these joints.
Generation of cyclo-oxygenase products by synovial tissue in culture appears to be independent of prior drug treatment. Tissues from patients receiving nonsteroid anti-inflammatory drugs such as indomethacin, flurbiprofen, or diclofenac, which are known to inhibit prostaglandin synthesis,2 do not have significantly less cyclo-oxygenase activity than tissues from patients receiving other drugs (Table 2 ). These observations are in agreement with the findings that preparations of human synovial microsomes from patients receiving indomethacin, naproxen, or ibuprofen did not have decreased cyclo-oxygenase activity.2" These authors reported, however, that tissues from patients taking aspirin did not generate prostaglandins in vitro, and they attributed this to an irreversible effect of aspirin which was not shared by other nonsteroid anti-inflammatory drugs. 
